Evidence map›Paper›PMID 30349348›Full record

ArticleInternational journal of general medicine2018

Primary hepatocellular carcinoma in a patient with history of treated breast cancer: a case report with challenging diagnosis and treatment.

Christoforos Kosmidis, Nikolaos Varsamis, Georgios Anthimidis, Sofia Baka, Dimitrios Valoukas, Triantafyllia Koletsa, Katerina Zarampouka, Georgios Koimtzis, Eleni Georgakoudi, Paul Zarogoulidis and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of general medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Christoforos KosmidisDepartment of Surgery, Interbalkan European Medical Center, Thessaloniki, Greece.
Nikolaos VarsamisDepartment of Surgery, Interbalkan European Medical Center, Thessaloniki, Greece.
Georgios AnthimidisDepartment of Surgery, Interbalkan European Medical Center, Thessaloniki, Greece.
Sofia BakaDepartment of Oncology, Interbalkan European Medical Center, Thessaloniki, Greece.
Dimitrios ValoukasDepartment of Oncology, General Hospital of Ptolemaida, Ptolemaida, Greece.
Triantafyllia KoletsaPathology Department, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Katerina ZarampoukaPathology Department, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Georgios KoimtzisThird Surgical Department, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Eleni GeorgakoudiAristotle University of Thessaloniki, Thessaloniki, Greece.
Paul ZarogoulidisPulmonary-Oncology Unit, "Theageneio" Cancer Hospital, Thessaloniki, Greece, pzarog@hotmail.com.
Christoforos EfthymiadisDepartment of Surgery, Interbalkan European Medical Center, Thessaloniki, Greece.
Interbalkan Medical Center · GRAristotle University of Thessaloniki · GRKAT General Hospital of Attica · GRTheageneio General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBreast cancer is the most common malignancy in women worldwide. Long-term survivors among patients treated for breast cancer are at a high risk for developing a second primary malignancy. Hepatocellular carcinoma is the most frequent primary hepatic malignancy and should be ruled out in breast cancer patients who are diagnosed with solitary hepatic lesions. False diagnosis may lead to inappropriate oncologic staging and treatment of the disease. CASE PRESENTATION: We present the case of a 73-year-old female patient who had been treated for invasive ductal breast cancer 7 years ago and was diagnosed with a solid hepatic lesion at segments VI and VII and a small, calcified lesion at the tail of the pancreas on follow-up with an abdominal computed tomography. Oncology council decided that both lesions could be resected after determining whether they were metastatic or second primary malignancies. The patient underwent laparotomy and rapid biopsy which showed primary hepatocellular carcinoma and fibrosis of the pancreas. We performed hepatic segmentectomy (VI-VII) and cholecystectomy, while the pancreatic lesion was left intact. The postoperative course of the patient was uncomplicated and she remains disease free 2 years after the operation without any adjuvant therapy.

conclusionAll hepatic lesions detected in breast cancer patients should be evaluated with open mind and liver biopsy should be performed to get a definitive diagnosis and implement the proper treatment strategy.

Indexed as

breast cancerhepatocellular cancermicrowave tissue coagulatorrapid biopsysecond primary malignancy

Identifiers

PMID30349348
PMCPMC6188071
OpenAlexW2897101139

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.